Utilization of molecular genetic approaches for colorectal cancer screening

被引:0
作者
Emelyanova, Marina A. [1 ]
Ikonnikova, Anna Y. [1 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, 32 Vavilov St, Moscow 119991, Russia
关键词
Colorectal cancer; Cancer screening; Non-invasive screening; Liquid biopsy; Polygenic risk score; MULTITARGET STOOL DNA; COLONOSCOPY; EXPRESSION; BIOMARKERS;
D O I
10.3748/wjg.v30.i46.4950
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The feasibility of population screening for colorectal cancer has been demonstrated in several studies. Most of these studies have considered individual characteristics, diagnostic approaches, epidemiological data, and socioeconomic factors. In this article, we comment on an editorial by Metaxas et al published in the recent issue of the journal. The authors emphasized the need to raise public awareness through health education programs and the possibility of using easily accessible non-invasive screening methods. Here, we focus on non-invasive molecular genetic approaches that can aid in colorectal cancer screening. On the one hand, we highlighted the use of tumor DNA/RNA markers directly for screening and, on the other hand, underline the use of polygenic risk assessment and hereditary predisposition to select individuals for more thorough cancer screening.
引用
收藏
页码:4950 / 4957
页数:9
相关论文
共 67 条
  • [41] Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
    Naber, Steffie K.
    Knudsen, Amy B.
    Zauber, Ann G.
    Rutter, Carolyn M.
    Fischer, Sara E.
    Pabiniak, Chester J.
    Soto, Brittany
    Kuntz, Karen M.
    Lansdorp-Vogelaar, Iris
    [J]. PLOS ONE, 2019, 14 (09):
  • [42] Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
    Niedermaier, Tobias
    Balavarca, Yesilda
    Brenner, Hermann
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (01) : 56 - 69
  • [43] Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
    Oh, Tae Jeong
    Oh, Hyun Il
    Seo, Yang Yei
    Jeong, Dongjun
    Kim, Changjin
    Kang, Hyoun Woo
    Han, Yoon Dae
    Chung, Hyun Cheol
    Kim, Nam Kyu
    An, Sungwhan
    [J]. CLINICAL EPIGENETICS, 2017, 9
  • [44] PGS Catalog, Colorectal cancer
  • [45] Pretto J., FDA Approves ColoSenseTM-Geneoscopy's Noninvasive Multi-target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
  • [46] Evaluation of the ctDNA LUNAR-2 Test In an Average Patient Screening Episode (ECLIPSE)
    Raymond, Victoria M.
    Higashi, Linda
    Marino, Enrique
    Lang, Kathryn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [47] Syndecan-2 Functions as a Docking Receptor for Pro-matrix Metalloproteinase-7 in Human Colon Cancer Cells
    Ryu, Heui-Young
    Lee, Jiseon
    Yang, Sanghwa
    Park, Haein
    Choi, Sojoong
    Jung, Kyeong-Cheon
    Lee, Seung-Taek
    Seong, Je-Kyung
    Han, Inn-Oc
    Oh, Eok-Soo
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (51) : 35692 - 35701
  • [48] Colorectal cancer screening by fecal immunochemical test or colonoscopy in France: how many people are actually covered? Focus on the Provence-Alpes-Cote d'Azur region
    Seitz, Jean-Francois
    Lapalus, David
    Arlotto, Sylvie
    Gentile, Stephanie
    Ettori, Florence
    Rinaldi, Yves
    Grandval, Philippe
    Delasalle, Patrick
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (04) : 405 - 410
  • [49] ACG Clinical Guidelines: Colorectal Cancer Screening 2021
    Shaukat, Aasma
    Kahi, Charles J.
    Burke, Carol A.
    Rabeneck, Linda
    Sauer, Bryan G.
    Rex, Douglas K.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (03) : 458 - 479
  • [50] Cancer statistics, 2023
    Siegel, Rebecca L.
    Miller, Kimberly D.
    Wagle, Nikita Sandeep
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (01) : 17 - 48